What’s up with PJT’s stock price?
Since the market downfall, PJT’s share price has remained relatively flat. All other public EB’s have nosedived.
Trending Content - Investment Banking Forum
| +190 | Just One More Year | 15 | 4h |
| +172 | Piper Sandler in talks to acquire PWP | 74 | 5d |
| +123 | UBS Appears to be Exploring Sale | 19 | 2d |
| +87 | Paradise Is Paradise | 8 | 1h |
| +77 | Drunk VP. How to manage? | 27 | 21h |
| +38 | How do I take my foot off the gas? (AN1) | 4 | 1d |
| +38 | Lazard US Views 2026/2027 | 13 | 1d |
| +32 | M&A is Paradise | 1 | 5d |
| +25 | Why did EVR succeed vs GHL or PWP that ended up getting acquired? | 7 | 2d |
| +24 | HR is starting to worry me, do I throw a hail mary during an upcoming chat with an MD? | 3 | 1h |
Career Resources
RSSG is probably going to town, so it makes up for lower M&A revenue
Haha completely forgot about RX. Although, brings up the point that every EB also has a decent RX biz.
HL is the only firm that breaks Rx out in financials. If you look at MD count, would say only HL and PJT are truly restructuring focused enough to be net well positioned in this environment. Rest of the EBs have too much M&A
Would expect rx comprises a larger share of PJT’s business than it does at most other boutiques
Fee backlog + counter cyclical RX business
Perferendis voluptatem et mollitia et. Magni et a a incidunt. Deserunt ad quod aspernatur repellat.
Est qui explicabo qui qui accusamus eos vitae aut. Nulla dolor magni voluptatum officia. Consectetur incidunt rerum et quis. Voluptate molestiae et qui alias reiciendis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...